Field of the Invention
[0001] This invention relates to the processing of photographic silver halide colour materials.
Another related patent application co-filed herewith is ...(Applicants ref 9993).
Background of the Invention
[0002] Our copending European application 92900247.5 describes a method of developing an
imagewise exposed silver halide colour material to provide sensitometric results of
reduced variability which comprises carrying out colour development in the presence
of one or a combination of black-and-white silver halide developing agents (termed
herein electron transfer agents - ETA's) incorporated in said silver halide colour
material in an inactive form from which the active form is released during processing,
whereby development in low activity conditions is accelerated while that in high
activity conditions is decelerated thus reducing the variability in the density versus
LogE curve (the characteristic curve) caused by changes in process variables such
as time, temperature, colour developing agent concentration and bromide ion concentration.
Model examples having the black-and-white silver halide developing agent present in
the developer solution are described.
[0003] The specification also mentions that when the black-and-white silver halide developing
agent is incorporated in the photographic material it is preferably in a form which
is inactive until processing takes place. For example it could be inactivated by a
blocking group which is hydrolysed off when the material is immersed in the developing
solution (which is usually alkaline).
Problem to be Solved by the Invention
[0004] The problem with known hydrolysable blocked pyrazolidone developing agents (BETA's)
is that they only unblock at the required pH if the compound is rather unstable. If
the compound is stable enough not to break down in the material they do not unblock
fast enough (or at all) to be useful.
Summary of the Invention
[0005] According to the present invention there is provided a method of processing a colour
photographic material comprising at least one silver halide emulsion layer having
associated therewith a dye image-forming coupler and which contains in a layer thereof
one or more compounds of the general formula:

wherein
T¹ and T² individually are releasable timing groups;
n and m individually are 0 or 1, at least one of n and m being 1;
ETA is a group which is released as an electron transfer agent;
x is 0, 1 or 2;
R is substituted or unsubstituted alkyl or aryl or a photographic ballast group
replacing a ring hydrogen;
R¹ is unsubstituted or substituted alkyl;
each R² is individually a subsituted or unsubstituted alkyl, aryl or heterocyclic
group, or a carbamoyl, carbonamido, suphamoyl, sulphonamido, ester or acid group,
Z is located at any ring position not adjacent to the ketocarbonyl group and is
a group having one of the formulae:

R³ is H;

―SO₂―R
4';
substituted or unsubstituted alkyl or aryl or a photographic ballast group;
R⁴ is unsubstituted or substituted alkyl, or aryl;
R
4' is unsubstituted or substituted alkyl, or aryl, or

R⁵ and R⁶ individually are hydrogen, or unsubstituted or substituted alkyl or aryl;
and
Y is 0, 1, 2 or 3;
which process includes the step of treating the material with a photographic colour
developer composition containing a binucleophile wherein the compound(s) of formula
(1) are chosen such that the low activity development is accelerated and the high
activity development decelerated thus leading to less variation in sensitometric results
under both high and low activity conditions.
Advantageous Effect of the Invention
[0006] The present colour photographic materials show the advantages of improved performance
in the colour developer where variations in process conditions have less effect than
previously on sensitometric performance, particularly in the case of multilayer colour
materials.
[0007] In the present invention not only are the low activity conditions accelerated by
the presently used ETA releasers but also high activity conditions are decelerated
thus leading to less variation in sensitometric results under both high and low activity
conditions. This means that the spread of the characteritic curves as in Figs 3-13
of the accompanying drawings is compressed.
[0008] It has been found, in particular, that the presence of the ETA releaser reduces variability
caused by variations in time and temperature of development, pH, bromide ion concentration
and colour developing agent concentration in the colour developer solution. The reduced
risk of sensitometric variations further means that replenishment rates can be reduced
thus resulting in less overflow and effluent. The often needed bromide ion removal
from the developer solution may also be avoidable.
Brief Description of the Drawings
[0009] Figures 1-13 in the accompanying drawings illustrate the results of the working Examples
below.
Detailed Description of the Invention
[0010] The alkyl groups represented by any of R to R⁶ may be alkyl groups having 1 to 25
carbon atoms, preferably 1 to 6 carbon atoms. Of the substituted groups, the substituents
may be halogen, alkyl, alkoxy, acyloxy, aroyloxy, keto, ether, ester, sulphonamide,
sulphamoyl, carbonamide, or carbamoyl groups.
[0011] The binucleophile to be contained in the colour developer solution can, for example,
be hydroxylamine, hydrogen peroxide, hydrazine all of which may be substituted or
a salt thereof.
[0012] Preferred ETA groups have the general formula:

wherein
each R⁷ is an alkyl or substituted alkyl group having 1-10 carbon atoms,
R⁸ is an aryl or substituted aryl group,
n is 0, 1, 2, 3 or 4.
[0013] A particularly preferred group of ETA groups have the general formula:

wherein
R⁹ and R¹⁰ are each hydrogen or an alkyl or alkoxy group having 1-3 carbon atoms,
or a substituted alkyl or alkoxy group having 1-7 carbon atoms, eg substituted with
an aryl or ester group,
R¹¹ and R¹² are each hydrogen or an alkyl or hydroxyalkyl group having 1-3 carbon
atoms,
and wherein at least one of R⁹ and R¹⁰ is not hydrogen except in the cases where R¹¹
is an acyloxyalkyl or aroyloxyalkyl group when R⁹ and R¹⁰ can both be hydrogen. These
ETA groups belong to type (1) described below.
[0014] As is known from European application 92900247.5, there are three types of behaviour
observed with different types of pyrazolidinone. The reduction of sensitivity to development
time is used as an example. Three broad types of behaviour for different ETA's can
be observed and these are as follows:
Type (1): A reduction of sensitometric spread with a retardation of overdevelopment
and an acceleration of the underdevelopment.
Type (2): A modest reduction of sensitometric spread with a general acceleration of
dye formation.
Type (3): A reduction in sensitometric spread with a general retardation of dye formation.
[0015] The use of Type (2) ETA's alone is therefore not part of the present invention.
[0016] Type (1) is the preferred behaviour exhibited by the preferred compounds especially
when used singly. Type (2) is another useful and beneficial behaviour and could, in
certain cases, be preferred over Type (1) if an increase in contrast or corresponding
trade-off was desired.
[0017] The present invention also includes the use of combinations of ETA's. Combinations
of Type (2) and (3), for example, can give an overall behaviour similar to or better
than Type (1). Combinations of Type (1) and (3) also give good results in that the
spread of the sensitometric curves is particularly well controlled.
[0018] Type (2) ETA groups may be of formula (4) or (5) in which R⁹, R¹⁰ are hydrogen or
alkyl of 1-3 carbon atoms and R¹¹ and R¹² are an alkyl or hydroxyalkyl group of 1-3
carbon atoms, eg -CH₂OH or -C₃H₇.
[0019] Type (3) ETA groups may be of formula (4) or (5) in which R⁹ to R¹² are each hydrogen
or alkyl of 1-12 carbon atoms, alkoxy 1-12 carbon atoms both of which may be substituted
and wherein the total number of carbon atoms in R⁹ to R¹² is at least 4.
[0020] It is recognised that the definitions of the above types of ETA are not mutually
exclusive. This is because it is difficult to find an appropriate definition which
is mutually exclusive. Examples of the three types are given below. Beyond that the
skilled worker will be able to determine to which type a particular ETA belongs by
carrying out the procedures described herein.
[0022] The present invention is particularly applicable to the processing of colour negative
film but is also applicable to other processes, eg colour paper. The material to be
processed comprises a support bearing at least one silver halide emulsion layer having
a colour coupler associated therewith. The term "associated therewith" here takes
its normal meaning in art. The coupler may be incorporated in the emulsion layer or
in a layer adjacent thereto. The preferred colour materials comprise three dye image
forming units each containing one or more emulsion layers having couplers associated
therewith and each sensitised to a different region of the spectrum. A typical colour
material would contain such units sensitised to blue, green and red light and capable
of forming yellow, magenta and cyan image dyes respectively.
[0023] Examples of colour photographic materials and methods of processing them are described
in Research Disclosure Item 308119, December 1989 published by Kenneth Mason Publications,
Emsworth, Hants, United Kingdom.
[0024] The following Examples are included for a better understanding of the invention.
EXAMPLE 1
[0025] Compound 1 was made into a dispersion in coupler solvent (1) (diethyl lauramide)
and solvent (2) (ethyl acetate) in the ratio, (Compound (1):Solvent (1): Solvent (2))
by weight of 1:2:3. The oil phase was then dispersed in gelatin to give 1.0 % Compound
1, 4.0 % gelatin.
[0026] Coatings were then made in which compound 1 was coated in a layer underneath a layer
containing the silver halide and coupler. This is shown in the table 1 below.

[0027] The BETA compound was coated in a range of levels 0.0, 0.05, 0.1, 0.2 and 0.4 g/sq.m.
The ETA released from the BETA is 4'-methoxyphenyl-pyrazolidinone.
EXAMPLE 2
[0028] The coatings of Example 1 were processed in standard C-41 developer, which contains
2g/l of hydroxylamine sulphate(HAS), for the following development times: 1, 2.5,
5 and 8 minutes. In Figure 2 the sensitometric response of the control coating for
these four development times is shown. In Figure 3 the effect of the highest coated
level of BETA for the same set of development times is shown with the curves from
the control plot superimposed. It can be seen that with BETA present the sensitometric
spread is reduced. This effect is similar to that shown by adding the ETA to the developer
but to a smaller extent. In Figure 4 the extent of sensitometric spread is plotted
against the coated level of BETA and it can be seen that sensitometric spread is reduced
as the level of BETA is increased.
EXAMPLE 3
[0029] Compound 1 is designed to release the ETA 4'-methoxy-1-phenylpyrazolidone by the
action of the binucleophile, hydroxylamine sulphate (HAS), which is in C-41 developer
at 2g/l. Hydroxylamine is present in C-41 developer as an anti-oxidant. In order to
demonstrate the action of hydroxylamine in releasing the ETA some C-41 developers
were made-up with a range of HAS levels of 0, 1, 2, 6, 24 and 60g/l. The control coating
and the one with the highest level of BETA (0.4g/sq.m) were processed in these developers
and the comparisons for HAS levels of 0, 6 and 60g/l are shown in Figures 5, 6 and
7 respectively. It can be seen that without HAS there is almost no effect from the
coated BETA, but there is when HAS is present. In Figure 1 the reduction in sensitometric
sensitivity is plotted against HAS level in the developer for a BETA (0.4g/sq.m) containing
coating and one without BETA. Here it can be seen that there is a small reduction
in sensitometric sensitivity with HAS increase for the coating without BETA but a
much greater reduction in the coating with BETA.
EXAMPLE 4
[0030] The following multilayer structures were prepared. The figures in parentheses are
coverages in g/m²:
super coat gelatin (1.0)
UV protection layer
High speed Blue sensitive silver halide (0.6) + yellow coupler (0.18)
Slow speed Blue sensitive silver halide (0.55) + yellow coupler (1.0)
Scavenger interlayer
High speed Green sensitive silver halide (0.79) + magenta coupler (0.11)
Medium speed Green sensitive silver halide (0.45) + magenta coupler (0.2)
Low speed Green sensitive silver halide (0.5) + magenta coupler (0.39)
Scavenger interlayer
High speed Red sensitive silver halide (1.0) + cyan coupler (0.16)
Medium speed Red sensitive silver halide (0.5) + cyan coupler (0.31)
Low speed Red sensitive silver halide (0.5) + cyan coupler (0.65)
Anti-halation layer
Film base / / / / / /
where the silver halide is a bromoiodide emulsion with an average 3% iodide. The following
variations in the nature, amount and position of the BETA compound(s) and their effect
on the sensitometric results illustrated in the Figures specified were as follows:
1. Single BETA in multilayer; Figs 8 and 9
a. Fig 8 compares a control with a BETA (Compound 8) incorporated in the anti-halation
layer of a multilayer at 1.0g/sq.metre. Solid lines are for the red record of the
control, dashed lines for the red record with the incorporated BETA. There is a small
amount of compression of the spread in sensitometry by the incorporation of the BETA.
b. Fig 9 compares a control with a BETA( Compound 10) incorporated at 0.33g/sq.metre
in both the fast and slow layers of the red sensitive pack of a multilayer. Solid
lines are for the red record of the control and the dashed lines for the red record
of the incorporated BETA. There is a moderate compression of the sensitometric spread
by incorporation of the BETA.
2. Combinations of BETAs in multilayer;
Figs 10, 11, 12, 13.
a. Fig 10 compares the red records of a control with a BETA (Compound 7) incorporated
in the anti-halation layer of a multilayer at 0.5g/sq.metre. This is an example of
a BETA which releases an accelerating ETA and consequently the dashed curves (BETA)
are in the main accelerated relative to solid curves of the control.
b. Fig 11 compares the red records of a control with a BETA (Compound 9) incorporated
in the anti-halation layer of a multilayer at 0.5g/sq.metre. This is an example of
a BETA which releases a retarding ETA and the dashed curves for the BETA are retarded
relative to the solid curves for the control.
c. Fig 12 compares the red records of a control with a combination of two BETAs, Compound
7 and Compound 9 incorporated in the anti-halation layer of a multilayer at 0.5g/sq.metre
each. This is an example of a combination of an accelerating and a retarding BETA.
The dashed curves of the BETA coating show that longer development times are retarded
and the shorter development times accelerated relative to the solid lines of the control.
d. Fig 13 compares the red records of the example of Fig 12 with an additional 0.4g/l
of 4'-methoxy-1-phenyl-3-pyrazolidinone in the developer used for the BETA incorporated
coating. In this case the longer development times are retarded and the short development
times accelerated to a greater extent than without the ETA in the developer.
1. A process of processing an imagewise exposed colour photographic material comprising
at least one silver halide emulsion layer having associated therewith a dye image-forming
coupler and which contains in a layer thereof one or more compounds of the general
formula:

wherein
T¹ and T² individually are releasable timing groups;
n and m individually are 0 or 1, at least one of n and m being 1;
ETA is a group which is released as an electron transfer agent;
x is 0, 1 or 2;
R is substituted or unsubstituted alkyl or aryl or a photographic ballast group
replacing a ring hydrogen;
R¹ is unsubstituted or substituted alkyl;
each R² is individually a subsituted or unsubstituted alkyl, aryl or heterocyclic
group, or a carbamoyl, carbonamido, suphamoyl, sulphonamido, ester or acid group,
Z is located at any ring position not adjacent to the ketocarbonyl group and is
a group having one of the formulae:

R³ is H;

―SO₂―R
4';
substituted or unsubstituted alkyl or aryl or a photographic ballast group;
R⁴ is unsubstituted or substituted alkyl, or aryl;
R
4' is unsubstituted or substituted alkyl, or aryl, or

R⁵ and R⁶ individually are hydrogen, or unsubstituted or substituted alkyl or
aryl; and
Y is 0, 1, 2 or 3;
which process includes the step of treating the material with a photographic colour
developer composition containing a binucleophile wherein the compound(s) of formula
(1) are chosen such that the low activity development is accelerated and the high
activity development decelerated thus leading to less variation in sensitometric results
under both high and low activity conditions.
2. A process as claimed in claim 1 in which the the ETA group has the general formula:

wherein
each R⁷ is an alkyl or substituted alkyl group having 1-10 carbon atoms,
R⁸ is an aryl or substituted aryl group,
n is 0, 1, 2, 3 or 4.
3. A process as claimed in claim 2 in which the ETA group has the general formula:

wherein
R⁹ and R¹⁰ are each hydrogen or an alkyl or alkoxy group having 1-3 carbon atoms,
or a substituted alkyl or alkoxy group having 1-7 carbon atoms, eg substituted with
an aryl or ester group,
R¹¹ and R¹² are each hydrogen or an alkyl or hydroxyalkyl group having 1-3 carbon
atoms,
and wherein at least one of R⁹ and R¹⁰ is not hydrogen except in the cases where R¹¹
is an acyloxyalkyl or aroyloxyalkyl group when R⁹ and R¹⁰ can both be hydrogen.
4. A process as claimed in claim 2 in which the ETA group has the general formula (4)
or (5) in which R⁹, R¹⁰ are hydrogen or alkyl of 1-3 carbon atoms and R¹¹ and R¹²
are an alkyl or hydroxyalkyl group of 1-3 carbon atoms, eg -CH₂OH or -C₃H₇.
5. A process as claimed in claim 2 in which the ETA group has the general formula (4)
or (5) in which R⁹ to R¹² are each hydrogen or alkyl of 1-12 carbon atoms, alkoxy
1-12 carbon atoms both of which may be substituted and wherein the total number of
carbon atoms in R⁹ to R¹² is at least 4.
6. A process as claimed in any of claims 1-5 in which the colour developing solution
contains a water-soluble electron transfer agent (ETA).
7. A process as claimed in any of claims 1-6 in which the ETA is a pyrazolidinone.